Amyotrophic lateral sclerosis (ALS)
Supplements studied for amyotrophic lateral sclerosis (ALS).
Overview
Four supplements are indexed for amyotrophic lateral sclerosis (ALS) across four studies, all with low ratings.
Intravenous N-Acetyl Cysteine (NAC) at 50 mg/kg daily for 12 months did not improve survival or slow progression in one study. Acetyl-L-Carnitine is uncertain: a small trial reported slower decline and longer survival with usual care, but evidence is not conclusive.
Lutein and Lycopene evidence comes mainly from large observational cohorts linking higher dietary carotenoid intake to lower ALS risk; lycopene alone did not show a clear association. See the heatmap and evidence reviews below for detail.
Effect graph
Subscribe to view effect graphs
Interactive visualisations of ranked conditions and clinical benefit with purchase guidance.
Already a subscriber? Sign in
Relevant supplements heatmap
Relevant supplements sorted by DEX Score.
Subscribe to view effect heatmaps
See effect size, evidence strength, and trust at a glance for every condition.
Already a subscriber? Sign in
SupplementDEX Database
5 supplements for and rated at least stars. All purchase bands. No minimum star filter.
Subscribe to access the SupplementDEX Database
Read this and 2,600+ other evidence reviews on our practitioner plan.
Already a subscriber? Sign in
Evidence visualised
Subscribe to view condition evidence
Visual summaries of supplement evidence ranked by condition.
Already a subscriber? Sign in